Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

HGS reports new chemokine polypeptides

July 5, 2000

First mechanism-based MMP inhibitor designed at Wayne State as potential anticancer agent

July 5, 2000

KNK-437: a novel inhibitor of the development of thermotolerance and HSP induction in cancer cells

July 5, 2000

Inhibitors of dual-specificity phosphatases inhibit growth of breast cancer cells

July 5, 2000

Cell Pathways reports positive one-year extension data from phase III Aptosyn study

July 5, 2000

Theratechnologies moves forward with PDT development program

July 5, 2000

Myriad Genetics to use investment funds for colon cancer research

July 5, 2000

Incyte and Baylor collaborate on genomic cancer research in children

July 5, 2000

Clinical trials of cancer gene therapy begin at Cobra Therapeutics

July 5, 2000

Prolifix enters agreement for cell cycle protein research

July 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.